07:41 AM EDT, 03/20/2025 (MT Newswires) -- Aurora Cannabis Inc. ( ACB ) , the Canada-based global medical cannabis company, was at last look up 1.15% in US premarket trade on Thursday as it announced the discovery of a novel source of genetic resistance against powdery mildew, PM2, that it says "provides strong protection against this pathogen in cannabis sativa".

In a statement Aurora said the development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is "set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year".